AI Assistant
Blog
Pricing
Log In
Sign Up
SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.